Greenfood majority stake changes hands
Financial terms were not disclosed.
Fidelio has held a minority stake in Greenfood for almost 15 years.
A Greenfood spokesperson confirmed to Just Food that management and employees now hold the remaining minority shares.
In a statement issued yesterday (28 July), Greenfood said the transaction will support its 'accelerated international expansion'.
'The company's capital structure, financial commitments and obligations remain unchanged,' it added.
Greenfood, known for its 'healthy, affordable, and sustainable' food, operates in both Europe and the US.
The Swedish company supplies fresh fruits and vegetables, as well as ready-made meals. It operates through three divisions: Fresh Produce, salad-bar business Picadeli and Food Solutions.
Since 2016, when Nordic Capital became the majority shareholder, Greenfood said it has nearly doubled its revenues to Skr5.6bn ($580.3m).
David von Laskowski, the CEO of Greenfood Group & Picadeli, said, 'As we turn this exciting page together with Fidelio, we are confident in our ability to further accelerate growth, foster innovation, and strengthen our positive impact.'
The deal is slated for completion in the second half of the year, contingent on regulatory approvals and other standard closing conditions.
Greenfood in its current form came about in 2015 through the merger of Picadeli and STC Greenfood. The following year, it was acquired by Stockholm-based private-equity firm Nordic Capital. In 2019, the company bought the fresh cut produce business of Finland's Apetit.
The company supplies customers in Sweden, Finland, Denmark, Norway, Estonia, Germany, Belgium, Luxembourg, France and the US, with sourcing operations in Spain.
"Greenfood majority stake changes hands" was originally created and published by Just Food, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
21 minutes ago
- Miami Herald
Several oil companies await U.S. licenses to resume Venezuela operations
About half a dozen international oil companies are waiting on U.S. government authorization to resume operations in Venezuela, months after their licenses were revoked amid rising tensions over the country's political crackdown and humanitarian crisis, according to a report in Reuters on Tuesday. The companies — including Eni (Italy), Repsol (Spain), Maurel & Prom (France), and Reliance Industries (India) — were previously key partners of Venezuela's state-run oil company, PDVSA. Together, they accounted for about 25% of the country's crude exports before the Trump administration canceled their licenses in March. The license revocations had marked a broader policy reversal, as Washington responded to what officials described as Nicolás Maduro's failure to uphold commitments tied to democratic reforms and migration cooperation. At the time, U.S. officials accused the regime of violating sanctions relief agreements. While the U.S. government has quietly renewed Chevron's license — a move that allows the Texas-based oil giant to restart operations in the South American nation — no similar decision has been announced for the other firms. According to Reuters, some of the companies have internally notified staff of expected licenses, but are still waiting for formal documents from the U.S. Treasury and State Departments. Most of the firms hold minority stakes in joint oil and gas ventures with PDVSA, while Reliance is one of Venezuela's largest crude buyers. The delay comes as the U.S. renews pressure on Caracas to restore democratic order. Secretary of State Marco Rubio reiterated on Monday that sanctions will remain in place unless the Maduro regime takes 'verifiable steps' toward democratic reform. Chevron's license, issued last week, was described by sources as a 'specific license' rather than a general one. This means that the details of the new license can be kept confidential, but the source said that it will allow the company to resume more regular operations with PDVSA under terms that reportedly include payment in barrels of oil rather than cash — a structure that may help Caracas bypass some financial restrictions. In a statement to the Miami Herald, the State Department said the license is intended solely to support maintenance work and debt repayment, and 'does not offer any financial relief to the Maduro regime.' 'While we cannot comment on specific licenses, the United States government will not allow the Maduro regime to profit from oil sales,' the department said in an emailed response. Still, analysts say the deal is likely to offer the Maduro government some indirect financial breathing room. Venezuela's debt to Chevron was estimated at about $3 billion before being reduced under the Biden administration's earlier authorization. That license was pulled in March as part of the broader sanctions rollback, and the restriction took effect in May. Before its suspension, Chevron accounted for roughly one-quarter of Venezuela's daily oil output — about 900,000 barrels per day earlier this year. The other international firms made up an additional 230,000 barrels per day.
USA Today
21 minutes ago
- USA Today
NBA sets schedule for 2025-26 games in Europe, unveils plans for 2027, 2028
The NBA on Wednesday announced its regular-season European schedule for the 2025-26 season and unveiled plans to play regular-season season games in Paris, Berlin and Manchester in 2027 and 2028. The Memphis Grizzlies and Orlando Magic will play two games in Europe this season – in Berlin on Jan. 15, and in London on Jan. 18. "Announcing the next three season's regular-season games in Europe reflects the incredible momentum and appetite for NBA basketball in France, Germany, the UK and across the region," NBA managing director of Europe and Middle East George Aivazoglou said in a news release. "We look forward to welcoming the Grizzlies and the Magic to Berlin and London and to engaging fans, players and the local communities through the games and the surrounding events." The Magic's Franz and Mo Wagner are from Germany, and the Berlin game will the NBA's first regular-season game in the country. "To have the Orlando Magic and the NBA play a regular-season game in our hometown of Berlin means everything to us," the Wagner brothers said in a joint statement. "Growing up here, we dreamed of moments like this. It's a huge honor to represent Berlin and Germany and show how much the city and country love basketball. We hope we can inspire kids the way we were inspired watching games from afar." Europe, get ready! ✈️🌍The NBA will host SIX regular-season games in Europe over the next three years, with games to come in Berlin and London (2026), Manchester and Paris (2027) and Berlin and Paris (2028).🗞️ The NBA's push into the European market has been steady and unsurprising. As the league considers expansion of its North American-based league, it is also exploring the creation a new league based in Europe – with the idea of adding already existing franchises and creating franchises in underserved markets. "Just as the same as in American cities, we think there's an opportunity to serve fans in Europe," NBA commissioner Adam Silver said at the NBA Finals. "No knock on European basketball, because most of those international MVPs I just talked about are coming from Europe. There's really high-level basketball being played there. But we think there is an opportunity to better serve fans there. I view that as a form of expansion as well, and that's something we're also thinking hard about."
CNBC
22 minutes ago
- CNBC
Novo Nordisk's stock plunge isn't surprising. Why companies clear the deck for new CEOs
Novo Nordisk shares nosedived on the day its new chief executive, Maziar Mike Doustdar, was appointed. But that shouldn't have come as a surprise to investors. Minutes before the news of Doustdar's appointment on Tuesday, the Danish pharmaceutical giant reported a profit warning, slashing its operating profit growth by around a third to the new normal of 10% to 16%. It also forecast slower-than-expected top-line growth. The company appears to have attempted to clear the deck for its new CEO, but far from being a unique strategy to reset expectations with investors, it has now become a "pretty common practice," according to Michael Field, Europe market strategist at Morningstar. Field said that companies do this to "give the new CEO a chance to succeed and hit the ground running, without having to deal with quarterly profit warnings for a year or more after they join." "If they can 'kitchen sink' earnings around the CEO appointment, then the new CEO should be quickly able to show improvement in the business, which is good for everyone involved, and of course, the share price," he added. Other Stoxx Europe 600 index companies have exhibited similar strategies. A tried-and-tested technique For instance, on June 9, Swedish medical device maker Elekta announced the appointment of its new CEO, Jakob Just-Bomholt. The following day, the company released the results of a "proactive" review to "improve the quality" of its orderbook, which showed that it was about 4.9 billion Swedish krona ($503.7 million) short of its previous estimate. The stock fell 4.7% — the biggest drop since April's U.S. tariff-related volatility. "A new CEO was announced yesterday, but the investor update on Tuesday brought some further surprises that one might normally have expected to be announced at a later date," said JPMorgan analyst David Adlington on June 10. "We note that one option for the new CEO to generate renewed investor interest could be to rebase the guidance." IT software and service company Tietoevry did the same on July 21. Endre Rangnes, who had been interim CEO since May, was officially confirmed as chief executive and President. The following day, the Finnish technology company reported its interim half-year report, which said organic growth would go into reverse by 4%. "While we can recognize our strengths and achievements, we have not succeeded in delivering adequate financial performance and have suffered from lack of growth over an extended period of time," Rangnes said in his second communique to investors as chief executive. The stock dropped 13% on the day. The automaker Renault also pulled off the tried-and-tested technique on July 15. Instead of making a dedicated alarmist filing, the company lowered its profit forecast for the year during its scheduled half-year results. It did, however, announce Duncan Minto as interim chief executive officer five minutes before its earnings. In Renault's case, the automaker had announced its new strategy only a month earlier under its former chief executive Luca de Meo, who abruptly exited the company to lead ailing luxury goods maker Kering . Renault's stock, which had already been bruised by the shock exit of its former CEO a month earlier, fell another 18.5%. The stock market is littered with many such examples of chief executive appointments that are immediately surrounded by profit warnings. "The CEO themselves may advocate for this as a condition of them joining," Morningstar's Field said. "Instead of uncovering mess after mess, the new CEO may simply ask the board to fully evaluate the business ailments beforehand and allow them a fresh start." 'Every situation is different' Yet, investors have been unable to model the behavior and look past efforts by companies to reset. Why? "Mainly because every business situation is different," Field said. "There are no hard and fast rules, which makes it tough for investors to know how much bad news has already come out, or when there is more to come." The case for "buying the dip" in the stock price on such supposedly predictive behavior from companies has also been challenging. "If a CEO is really clearing the deck, then there is likely a lot of bad news already priced in to the shares as a result," Field said. "That said, every situation is different, and investors really need to assess if a change of leadership can actually fix the business or if there are structural issues that will continue to lead to worsening results." Woes with Novo Nordisk's share price are well understood among investors. The stock had declined by more than 60% since its all-time high in June 2024 on disappointing topline growth of its blockbuster weight loss drugs. Perhaps the reset in guidance from Novo was warranted, since investors punished its U.S. competitor Eli Lilly too, sending its shares lower by 5.6%.
